BOSTON--(BUSINESS WIRE)--PHT Corporation accomplished a significant new ePRO industry milestone as it announced its 400th clinical trial. PHT is the leading provider of ePRO solutions used in pharmaceutical and biotechnology clinical trials worldwide. PHT President and CEO Phil Lee said, “This is a remarkable achievement not just for PHT, but for the industry. Our customers have made ePRO the standard because of the unsurpassed data quality that it yields. Pharmaceutical and biotech sponso
For more information, please visit
http://www.businesswire.com/news/home/20090908006065/en